Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$13.70 USD

13.70
156,608

+0.51 (3.87%)

Updated Aug 13, 2025 04:00 PM ET

After-Market: $13.73 +0.03 (0.22%) 7:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (169 out of 245)

Industry: Food - Miscellaneous

Zacks News

Zacks Equity Research

Kellogg (K) Benefits From EMEA Region, High Costs a Worry

Kellogg Company (K) has been benefiting from strength in the EMEA region and its robust snacks business, especially Pringles. However, cost headwinds prevail.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)

Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

Campbell (CPB) Q3 Earnings Top Estimates, Sales Rise Y/Y

Campbell Soup's (CPB) third-quarter fiscal 2022 results reflect higher net sales and earnings on growth across all segments. Management raises its fiscal 2022 sales view.

Zacks Equity Research

The Estee Lauder Companies' (EL) Latest Move Aids Travel Retail

The Estee Lauder Companies (EL) opens a 300,000 square feet state-of-the-art distribution center in Galgenen dedicated to its global Travel Retail business.

Zacks Equity Research

United Natural Foods (UNFI) Q3 Earnings & Sales Top Estimates

United Natural Foods' (UNFI) third-quarter fiscal 2022 results reflect higher earnings and sales, with all channels witnessing sales growth. Management updates fiscal 2022 guidance.

Zacks Equity Research

The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Rise

The J.M. Smucker's (SJM) fourth-quarter fiscal 2022 results reflect higher sales, sustained demand and strength in the company's brands. However, cost inflation persists.

Zacks Equity Research

The Estee Lauder Companies' (EL) Skin Care Sales Aids Growth

The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. It is benefiting from strong presence in emerging markets.

Zacks Equity Research

Molson Coors (TAP) Rises 17% YTD: Here's What You Should Know

Although rising inflation remains concerning, brand strength, product innovation and revitalization plan bode well for Molson Coors (TAP).

Zacks Equity Research

Monster Beverage (MNST) Stock Looks Well-Poised Amid Cost Woes

Despite freight issues and elevated aluminum can costs, Monster Beverage's (MNST) continued momentum in the energy drinks category and a robust new product pipeline bode well.

Zacks Equity Research

Altria (MO) Benefits From Solid Pricing, High Costs a Worry

Altria (MO) has been benefiting from its solid pricing power and efforts toward expanding in the oral tobacco products space, while escalation in certain costs is a concern.

Zacks Equity Research

Chewy (CHWY) Posts Q1 Earnings Beat & Higher Revenues Y/Y

Chewy's (CHWY) first-quarter fiscal 2022 results reflect gains from its strategic moves and strength in the pet category.

Zacks Equity Research

Tyson Foods (TSN) Gains on Protein Demand & Capacity Expansion

Tyson Foods (TSN) is focused on higher protein production to cater to the rising demand for protein-packed food. Also, capacity expansion efforts are yielding.

Zacks Equity Research

Hormel Foods (HRL) Q2 Earnings Top Estimates on Solid Pricing

Hormel Foods' (HRL) second-quarter fiscal 2022 results reflect higher earnings and sales, backed by strength across brands and solid pricing.

Zacks Equity Research

Nu Skin (NUS) Looks Troubled on Volatile Currency Movements

Nu Skin Enterprises (NUS) has been encountering global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.

Zacks Equity Research

Philip Morris (PM) Gains on Solid Pricing, High Costs a Worry

Philip Morris (PM) has been benefiting from its solid pricing power and efforts toward expanding in the reduced risk products space, while escalation in certain costs has been hurting margins.

Zacks Equity Research

High Demand & Online Strength Aid Newell (NWL) Amid Inflation

Newell (NWL) looks promising on the back of sturdy demand, product innovation and solid online show despite inflation and supply-chain headwinds.

Zacks Equity Research

Conagra Brands (CAG) Troubled by Inflation in Cost of Goods

Conagra Brands (CAG) has been encountering cost of goods sold inflation for a while now. Gross inflation is likely to be roughly 16% in fiscal 2022.

Zacks Equity Research

Should Value Investors Buy MEDIFAST (MED) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Flowers Foods (FLO) on Track to Boost Shareholder Returns

Flowers Foods (FLO) is hiking its dividend by 4.8% to boost shareholder wealth. The company increased its share repurchase authorization by 20 million shares.

Zacks Equity Research

General Mills (GIS) to Sell Helper Business, Reshape Portfolio

General Mills' (GIS) deal to divest the Helper main meals and Suddenly Salad side dishes businesses goes in tandem with the company's Accelerate strategy.

Zacks Equity Research

General Mills (GIS) Gains on Accelerate Strategy & Pet Unit Sales

General Mills (GIS) is on track with its three key priorities for fiscal 2022, which align with the Accelerate strategy. Solid Pet segment sales are a key driver.

Zacks Equity Research

Lamb Weston (LW) Up on Pricing Action & Foodservice Rebound

Lamb Weston (LW) is benefiting from robust price/mix for a while. Also, the company is focused on undertaking strategic growth efforts like expanding capacity.

Zacks Equity Research

United Natural's (UNFI) Growth Pillars & Online Sales Solid

United Natural (UNFI) is on track to undertake growth initiatives under its future pillar, including brands, professional services and fresh.

Zacks Equity Research

Flowers Foods (FLO) Stock Up on Q1 Earnings Beat & Sales Growth

Flowers Foods' (FLO) first-quarter fiscal 2022 results reflect higher sales and earnings. Management raised its fiscal 2022 sales guidance range.

Zacks Equity Research

Sysco's (SYY) Latest Move to Enhance Delivery to Aid Growth

Sysco (SYY) and Daimler Truck North America unveil a Letter of Intent to allocate up to around 800 battery electric Freightliner eCascadia Class 8 tractors to cater to Sysco's U.S. customers by 2026.